<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63586">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01680237</url>
  </required_header>
  <id_info>
    <org_study_id>BoSPmA</org_study_id>
    <nct_id>NCT01680237</nct_id>
  </id_info>
  <brief_title>Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia</brief_title>
  <official_title>Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruhr University of Bochum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruhr University of Bochum</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Panic disorder with agoraphobia is a prevalent and one of the most handicapping anxiety
      disorders. Although the efficacy of psychological treatment for panic disorder with
      agoraphobia has been the subject of a great deal of research, studies comparing
      cognitive-behavioral therapy and exposure in vivo have regularly been underpowered to detect
      small to moderate differences. Therefore, the primary purpose of the present study is to
      investigate if the combination of cognitive techniques with exposure in vivo is superior to
      the the effects of exposure alone for patients with moderate to severe agoraphobia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change (from baseline) in the Mobility Inventory</measure>
    <time_frame>0, 6, 12 month after treatment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change (from baseline) in a Behavioral Approach Test</measure>
    <time_frame>0, 6, 12 month after treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Participants are asked to go up a high and narrow church tower. The test yields number of floors (0-10) the patient achieves, recording the experienced anxiety level (0-100).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change (from baseline) in the Anxiety Disorder Interview Schedule</measure>
    <time_frame>0, 6, 12 month after treatment</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Panic Disorder With Agoraphobia</condition>
  <arm_group>
    <arm_group_label>Cognitive behavior therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Identification of bodily sensations, cognitions and safety behaviors characteristic of the individual patient
Modification of dysfunctional beliefs and assumptions using socratic questioning and behavioral experiments
Exposure in-vivo
Relapse prevention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exposure in-vivo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preparation of a brief behavior analysis of the individual case and construction of a hierarchy of relevant (internal and external) phobic situations
Exposure with internal stimuli
Exposure with external stimuli
Relapse prevention
Remark: In this condition there is no active work with the patient`s catastrophic cognitions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive behavior therapy</intervention_name>
    <arm_group_label>Cognitive behavior therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exposure in-vivo</intervention_name>
    <arm_group_label>Exposure in-vivo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of panic disorder with agoraphobia by trained clinician using a structured
             interview

          -  The anxiety disorder is considered to be the patient`s main current problem

          -  Age between 18 and 65 years

          -  The patient has agreed to participate in the study

        Exclusion Criteria:

        - Diagnosis of bipolar disorder, psychotic disorder, alcohol/substance abuse or dependency
        (within past 3 months), prominent risk of self-harm, organic mental disorder; concurrent
        psychotherapeutic or psychopharmacological treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tobias Teismann, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ruhr-Universität Bochum</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tobias Teismann, Dr.</last_name>
    <phone>0049-234-3227787</phone>
    <email>tobias.teismann@rub.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juergen Margraf, Prof. Dr.</last_name>
    <phone>0049-234-3223169</phone>
    <email>juergen.margraf@rub.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zentrum für Psychotherapie</name>
      <address>
        <city>Bochum</city>
        <state>NRW</state>
        <zip>44787</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Teismann, Dr.</last_name>
      <phone>0049-234-3227787</phone>
      <email>tobias.teismann@rub.de</email>
    </contact>
    <investigator>
      <last_name>Tobias Teismann, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 3, 2012</lastchanged_date>
  <firstreceived_date>August 17, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruhr University of Bochum</investigator_affiliation>
    <investigator_full_name>Dr. Tobias Teismann</investigator_full_name>
    <investigator_title>Dr. Tobias Teismann</investigator_title>
  </responsible_party>
  <keyword>cognitive behavior therapy</keyword>
  <keyword>exposure in-vivo</keyword>
  <keyword>panic disorder with agoraphobia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Agoraphobia</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
